On October 3, 2025, President Trump announced a sweeping drug pricing initiative called “TrumpRx,” designed to deliver up to 60% discounts on select medications purchased through federal health programs. The plan includes direct price negotiations with manufacturers, importation of lower-cost drugs from approved countries, and expanded use of biosimilars to reduce dependency on high-cost brand-name…
Why GSA Schedules Matter for Federal Vendors The GSA Schedule is a pre-approved contract vehicle. It allows vendors to sell directly to federal agencies without lengthy negotiations.Over $40 billion flows through this system annually. That’s a massive opportunity for businesses ready to scale. Getting listed means your pricing, terms, and capabilities are already vetted. It…
This week, USA Rare Earth’s magnet strategy took centre stage as the company announced a $100 million acquisition of Less Common Metals, a U.K.-based alloy producer. The move is designed to expand refining and magnet manufacturing capacity at its Oklahoma facility, giving the U.S. a stronger foothold in a sector long dominated by China. With…
Volvo has announced plans to produce a new hybrid vehicle in the United States, a move that highlights both market opportunity and trade realities. The decision comes as global automakers feel the heat from rising U.S. tariffs on imported cars. By committing to Volvo hybrid model production in its South Carolina plant, the company is…
Canary Capital has filed for a new crypto ETF. It focuses on U.S.-origin digital assets. This move has triggered speculation around XRP, Solana, and Cardano.“We want to spotlight American innovation in blockchain,” said Canary’s spokesperson. Why This ETF Matters Most crypto ETFs focus on Bitcoin or Ethereum. Canary’s proposal is different. It targets blockchains with…
Marvell Technology is gaining attention. Analysts say it may be undervalued in the AI chip race. Its stock is down, but its AI potential is rising.“Marvell is quietly building the backbone of AI infrastructure,” said The Motley Fool. What’s Happening with Marvell? Marvell builds custom silicon for data centers. It powers AI workloads for hyperscalers…
Labor Law Compliance Labor law compliance is becoming a top priority in federal contracting, and the life sciences industry is feeling the effects. With more oversight from the Department of Labor and federal agencies, contractors must show they are meeting rules around wages, workplace safety, benefits, and worker protections. For life sciences companies working on…
Seventeen U.S. state officials are urging BlackRock, State Street, and others to stay committed to ESG investing. The letter warns against abandoning long-term sustainability goals due to political pressure. “We expect you to act in the best interest of long-term investors,” the officials wrote. Who’s Involved? These firms manage trillions in assets. Their ESG policies…
Brazilian manufacturer WEG is making big waves with its decision to expand its U.S. transformer plant in Washington, Missouri. With a $77 million investment, the company plans to boost production capacity by nearly 50% by 2028. The move isn’t random—it’s fuelled by skyrocketing demand for electricity from artificial intelligence and data centres. As AI continues…
FDA’s Vision for Transparency and Accountability The latest FDA regulatory update is drawing attention across the life sciences and government contracting world. Dr. Marty Makary’s vision of a “New FDA” centers on increasing transparency, streamlining the approval process, and promoting stronger accountability in how medical products reach the market. For contractors tied to federal health…